Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Leuprorelin acetate
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Prostap 3 DCS 11.25mg inj pre-filled syringes
0803042N0BBADAD
|
Prostap | Leuprorelin acetate | Malignant Disease and Immunosuppression | 49,255 |
|
Leuprorelin 11.25mg inj pre-filled syringes
0803042N0AAADAD
|
Leuprorelin acetate | Leuprorelin acetate | Malignant Disease and Immunosuppression | 17,288 |
|
Prostap SR DCS 3.75mg inj pre-filled syringes
0803042N0BBACAC
|
Prostap | Leuprorelin acetate | Malignant Disease and Immunosuppression | 12,338 |
|
Leuprorelin 3.75mg inj pre-filled syringes
0803042N0AAACAC
|
Leuprorelin acetate | Leuprorelin acetate | Malignant Disease and Immunosuppression | 4,442 |
|
Staladex 11.25mg implant pre-filled syringes
0803042N0BDAAAF
|
Staladex | Leuprorelin acetate | Malignant Disease and Immunosuppression | 546 |
|
Leuprorelin 11.25mg implant pre-filled syringes
0803042N0AAAFAF
|
Leuprorelin acetate | Leuprorelin acetate | Malignant Disease and Immunosuppression | 215 |
|
Leuprorelin 1.88mg inj pre-filled syringes
0803042N0AAAGAG
|
Leuprorelin acetate | Leuprorelin acetate | Malignant Disease and Immunosuppression | 121 |
|
Lutrate 1 month Depot 3.75mg inj vials
0803042N0BCAAAA
|
Lutrate | Leuprorelin acetate | Malignant Disease and Immunosuppression | 5 |
|
Prostap PD DCS 1.88mg inj pre-filled syringes
0803042N0BBAEAG
|
Prostap | Leuprorelin acetate | Malignant Disease and Immunosuppression | 3 |
|
Prostap SR 3.75mg inj vials
0803042N0BBAAAA
|
Prostap | Leuprorelin acetate | Malignant Disease and Immunosuppression | 2 |
|
Leuprorelin 11.25mg inj vials
0803042N0AAABAB
|
Leuprorelin acetate | Leuprorelin acetate | Malignant Disease and Immunosuppression | No data available |
|
Leuprorelin 22.5mg inj vials
0803042N0AAAEAE
|
Leuprorelin acetate | Leuprorelin acetate | Malignant Disease and Immunosuppression | No data available |
|
Leuprorelin 3.75mg inj vials
0803042N0AAAAAA
|
Leuprorelin acetate | Leuprorelin acetate | Malignant Disease and Immunosuppression | No data available |
|
Lutrate 3 month Depot 22.5mg inj vials
0803042N0BCABAE
|
Lutrate | Leuprorelin acetate | Malignant Disease and Immunosuppression | No data available |
|
Prostap 3 Depot 11.25mg inj vials
0803042N0BBABAB
|
Prostap | Leuprorelin acetate | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.